Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole-based dual therapy for Helicobacter pylori eradication
ChiCTR2200066284Phase 4Not yet recruiting
- Sponsor
- Civil Aviation General Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ilaprazole in Helicobacter pylori infection (2 arms), sponsored by Civil Aviation General Hospital. Primary endpoint: Elimination rate of Helicobacter pylori. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
ilaprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200066284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066284.